Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials

BACKGROUND: Non‐high‐density lipoprotein cholesterol (non‐HDL‐C) and apolipoprotein (apo) B are better predictors of atherosclerotic cardiovascular disease risk than low‐density lipoprotein cholesterol alone. US and European lipid management guidelines support non‐HDL‐C and apoB as targets for lipid...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Am Heart Assoc
Huvudupphovsmän: Bays, Harold E., Leiter, Lawrence A., Colhoun, Helen M., Thompson, Desmond, Bessac, Laurence, Pordy, Robert, Toth, Peter P.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2017
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586424/
https://ncbi.nlm.nih.gov/pubmed/28862926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.005639
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk